Rapid dynamics of polyomavirus type BK in renal transplant recipients.

BACKGROUND Polyomavirus type BK-associated nephropathy (PVAN) is an emerging cause of early renal transplant failure. No specific antiviral treatment has been established. Current interventions rely on improving immune functions by reducing immunosuppression. In patients with PVAN, a high BK virus (BKV) load is detectable in plasma. However, the relationship between BKV replication and disease is not well understood. METHODS In a retrospective analysis of BKV plasma load in renal transplant recipients undergoing allograft nephrectomy (n = 3) or changes in immunosuppressive regimen (n = 12), we calculated viral clearance rates and generation times and estimated the loss of BKV-infected renal cells. RESULTS After nephrectomy, BKV clearance was fast (viral half-life [t(1/2)], 1-2 h) or moderately fast (t(1/2), 20-38 h), depending on the sampling density, but it was independent of continued immunosuppressive regimens. After changing immunosuppressive regimens, BKV was cleared with a t(1/2) of 6 h-17 days. Using the basic reproductive ratio, the efficacies of intervention ranged from 7% to 83% (mean, 28%; median, 22%). CONCLUSION The results emphasize that high-level BKV replication is a major pathogenetic factor that may have implications for genome rearrangements, immune evasion, and antiviral resistance.

[1]  Huldrych F. Günthard,et al.  Quantification of In Vivo Replicative Capacity of HIV‐1 in Different Compartments of Infected Cells , 2001, Journal of acquired immune deficiency syndromes.

[2]  Sebastian Bonhoeffer,et al.  Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis , 1999, The Lancet.

[3]  A S Perelson,et al.  Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. , 1998, Science.

[4]  M. Suthanthiran,et al.  Polyomavirus-Associated Nephropathy in Renal Transplantation: Interdisciplinary Analyses and Recommendations , 2005, Transplantation.

[5]  J. Fink,et al.  BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program. , 2002, Clinical transplants.

[6]  G. Botti,et al.  Polyomavirus BK-specific immunity after kidney transplantation. , 2004, Transplantation.

[7]  J. Fishman BK virus nephropathy--polyomavirus adding insult to injury. , 2002, The New England journal of medicine.

[8]  S. Finkelstein,et al.  Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy1 , 2002, Transplantation.

[9]  Alan S. Perelson,et al.  Kinetics of Acute Hepatitis B Virus Infection in Humans , 2000, The Journal of experimental medicine.

[10]  H. Hirsch BK virus: opportunity makes a pathogen. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  P. Randhawa,et al.  Effect of Leflunomide and Cidofovir on Replication of BK Virus in an In Vitro Culture System , 2005, Transplantation.

[12]  L M Wahl,et al.  Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection , 1997, Journal of virology.

[13]  T. Klimkait,et al.  Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. , 2000, The New England journal of medicine.

[14]  A. Perelson,et al.  Effects of Antibody on Viral Kinetics in Simian/Human Immunodeficiency Virus Infection: Implications for Vaccination , 2004, Journal of Virology.

[15]  M A Nowak,et al.  Viral dynamics in hepatitis B virus infection. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Steiger,et al.  Polyomavirus BK. , 2003, The Lancet. Infectious diseases.

[17]  A. Perelson Modelling viral and immune system dynamics , 2002, Nature Reviews Immunology.

[18]  S. Leung,et al.  Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  J. Papadimitriou,et al.  Histological Patterns of Polyomavirus Nephropathy: Correlation with Graft Outcome and Viral Load , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[20]  Emilio Ramos,et al.  Polyomavirus-associated nephropathy in renal transplantation , 2006 .

[21]  A. J. Hall Infectious diseases of humans: R. M. Anderson & R. M. May. Oxford etc.: Oxford University Press, 1991. viii + 757 pp. Price £50. ISBN 0-19-854599-1 , 1992 .

[22]  S. Finkelstein,et al.  Human polyoma virus-associated interstitial nephritis in the allograft kidney. , 1999, Transplantation.

[23]  A. Neumann,et al.  Hepatitis C Virus Kinetics , 1999, Antiviral therapy.

[24]  M. Imperiale,et al.  BKV and SV40 infection of human kidney tubular epithelial cells in vitro. , 2004, Virology.

[25]  Vincent C. Emery,et al.  The Dynamics of Human Cytomegalovirus Replication in Vivo , 1999, The Journal of experimental medicine.

[26]  T. Klimkait,et al.  Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. , 2002, The New England journal of medicine.